|
1
|
Fang LL, Wang XH, Sun BF, Zhang XD, Zhu
XH, Yu ZJ and Luo H: Expression, regulation and mechanism of action
of the miR-17-92 cluster in tumor cells (Review). Int J Mol Med.
40:1624–1630. 2017.PubMed/NCBI
|
|
2
|
Liu H, Lei C, He Q, Pan Z, Xiao D and Tao
Y: Nuclear functions of mammalian MicroRNAs in gene regulation,
immunity and cancer. Mol cancer. 17:642018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tang A, Hallouch O, Chernyak V, Kamaya A
and Sirlin CB: Epidemiology of hepatocellular carcinoma: target
population for surveillance and diagnosis. Abdom Radiol. 43:13–25.
2018. View Article : Google Scholar
|
|
4
|
Yegin EG, Oymaci E, Karatay E and Coker A:
Progress in surgical and nonsurgical approaches for hepatocellular
carcinoma treatment. Hepatobiliary Pancreat Dis Int. 15:234–256.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tian Q, Xiao Y, Wu Y, Liu Y, Song Z, Gao
W, Zhang J, Yang J, Zhang Y, Guo T, et al: MicroRNA-33b suppresses
the proliferation and metastasis of hepatocellular carcinoma cells
through the inhibition of Sal-like protein 4 expression. Int J Mol
Med. 38:1587–1595. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu WL, Wang WY, Yao WQ and Li GD:
Suppressive effects of microRNA-16 on the proliferation, invasion
and metastasis of hepatocellular carcinoma cells. Int J Mol Med.
36:1713–1719. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Li C, Jiang Y, Miao R, Qu K, Zhang J and
Liu C: MicroRNA-1271 functions as a metastasis and
epithelial-mesenchymal transition inhibitor in human HCC by
targeting the PTP4A1/c-Src axis. Int J Oncol. 52:536–546.
2018.PubMed/NCBI
|
|
8
|
Xia ZS, Wang L, Yu T, Zhong W, Lian GD, Wu
D, Zhou HM and Chen GC: MiR-5000-3p and miR-5009 3P and miR-552:
potential microRNA biomarkers of side population cells in colon
cancer. Oncol Rep. 32:589–596. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang J, Li H, Wang Y, Wang L, Yan X, Zhang
D, Ma X, Du Y, Liu X and Yang Y: MicroRNA-552 enhances metastatic
capacity of colorectal cancer cells by targeting a disintegrin and
metal-loprotease 28. Oncotarget. 7:70194–70210. 2016.PubMed/NCBI
|
|
10
|
Brabletz T, Kalluri R, Nieto MA and
Weinberg RA: EMT in cancer. Nat Rev Cancer. 18:128–134. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livak and Schmittgen: Analysis of relative
gene expression data using real-time quantitative PCR and the
2-ΔΔCt method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
12
|
Li C, Jiang Y, Miao R, Qu K, Zhang J and
Liu C: MicroRNA-1271 functions as a metastasis and
epithelial-mesenchymal transition inhibitor in human HCC by
targeting the PTP4A1/c-Src axis. Int J Oncol. 52:536–546.
2018.PubMed/NCBI
|
|
13
|
Duseja A: Staging of hepatocellular
carcinoma. J Clin Exp Hepatol. 4:S74–S79. 2014. View Article : Google Scholar
|
|
14
|
Anton L, DeVine A, Sierra LJ, Brown AG and
Elovitz MA: miR-143 and miR-145 disrupt the cervical epithelial
barrier through dysregulation of cell adhesion, apoptosis and
proliferation. Sci Rep. 7:30202017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Akgul Y, Word RA, Ensign LM, Yamaguchi Y,
Lydon J, Hanes J and Mahendroo M: Hyaluronan in cervical epithelia
protects against infection-mediated preterm birth. J Clin Invest.
124:5481–5489. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lou W, Liu J, Gao Y, Zhong G, Chen D, Shen
J, Bao C, Xu L, Pan J, Cheng J, et al: MicroRNAs in cancer
metastasis and angiogenesis. Oncotarget. 8:115787–115802. 2017.
View Article : Google Scholar
|
|
17
|
Zhang Y, Wei Y, Li X, Liang X, Wang L,
Song J, Zhang X, Zhang C, Niu J, Zhang P, et al: microRNA-874
suppresses tumor proliferation and metastasis in hepatocellular
carcinoma by targeting the DOR/EGFR/ERK pathway. Cell Death Dis.
9:1302018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang XY, Wu MH, Liu F, Li Y, Li N, Li GY
and Shen SR: Differential miRNA expression and their target genes
between NGX6-positive and negative colon cancer cells. Mol Cell
Biochem. 345:283–290. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Oberg AL, French AJ, Sarver AL,
Subramanian S, Morlan BW, Riska SM, Borralho PM, Cunningham JM,
Boardman LA, Wang L, et al: miRNA expression in colon polyps
provides evidence for a multihit model of colon cancer. PLoS One.
6:e204652011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Cui YM, Han XH, Lin YY, Lv WW and Wang YL:
TNF-alpha was involved in calcium hydroxide-promoted osteogenic
differentiation of human DPSCs through NF-kappaB/p38MAPK/Wnt
pathway. Die Pharmazie. 72:329–333. 2017.
|
|
21
|
Rankin SA, McCracken KW, Luedeke DM, Han
L, Wells JM, Shannon JM and Zorn AM: Timing is everything:
Reiterative Wnt, BMP and RA signaling regulate developmental
competence during endoderm organogenesis. Dev Biol. 434:121–132.
2018. View Article : Google Scholar
|
|
22
|
Chen J, Rajasekaran M and Hui KM: Atypical
regulators of Wnt/beta-catenin signaling as potential therapeutic
targets in hepatocellular carcinoma. Exp Biol Med. 242:1142–1149.
2017. View Article : Google Scholar
|
|
23
|
Zheng Y, Li X, Jiang Y, Xu Y, Song B, Zhou
Q, Liang X and Yang X: Promoter hypermethylation of Wnt inhibitory
factor-1 in patients with lung cancer: A systematic meta-analysis.
Medicine. 95:e54332016. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Guo H, Zhou S, Tan L, Wu X, Wu Z and Ran
R: Clinicopathological significance of WIF1 hypermethylation in
NSCLC, a meta-analysis and literature review. Oncotarget.
8:2550–2557. 2017.
|
|
25
|
Schmid SC, Sathe A, Guerth F, Seitz AK,
Heck MM, Maurer T, Schwarzenböck SM, Krause BJ, Schulz WA, Stoehr
R, et al: Wntless promotes bladder cancer growth and acts
synergistically as a molecular target in combination with
cisplatin. Urol Oncol. 35:544.e1-544.e102017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo W, Shen F, Xiao W, Chen J and Pan F:
Wnt inhibitor XAV939 suppresses the viability of small cell lung
cancer NCI-H446 cells and induces apoptosis. Oncol Lett.
14:6585–6591. 2017.
|
|
27
|
Wu C, Zhuang Y, Jiang S, Liu S, Zhou J, Wu
J, Teng Y, Xia B, Wang R and Zou X: Interaction between
Wnt/beta-catenin pathway and microRNAs regulates
epithelial-mesenchymal transition in gastric cancer (Review). Int J
Oncol. 48:2236–2246. 2016. View Article : Google Scholar : PubMed/NCBI
|
